ArticleBiomolecules2026

STY12, a Novel NQO1/HDAC Dual-Targeting Agent, Exhibits Potent Anti-Pancreatic Cancer Activity by ROS-Mediated DNA Damage.

Tong Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.